These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7261475)

  • 1. Kinetic studies of the association of complement components and IgG-coated latex particles incubated in normal or complement-activated human serum.
    Hällgren R
    Clin Exp Immunol; 1981 Apr; 44(1):191-200. PubMed ID: 7261475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human serum inhibits the interaction between C1q or rheumatoid factor and IgG-coated latex particles. Reduction of these C1-dependent properties after complement activation in vitro and in vivo.
    Hällgren R
    Immunology; 1979 Nov; 38(3):529-37. PubMed ID: 118112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic measurement of the interaction of rheumatoid factor with IgG-coated latex particles and the influence of the first component of human complement.
    Hällgren R
    Clin Exp Immunol; 1980 Jan; 39(1):154-63. PubMed ID: 6771071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
    Håkansson L; Hällgren R; Venge P
    Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of the agglutination of IgG-coated latex particles by C1q: the influence of heat-labile serum components.
    Hällgren R; Stålenheim G; Venge P
    Scand J Immunol; 1979; 9(4):365-72. PubMed ID: 441683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the binding ability and the rate of activation of the complement component C1.
    Folkerd EJ; Gardner B; Hughes-Jones NC
    Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates.
    Doekes G; Vanes LA; Daha MR
    Immunology; 1982 Apr; 45(4):705-13. PubMed ID: 7068172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement fixing properties of antibodies to double-stranded DNA in systemic lupus erythematosus.
    Gharavi AE; Elkon KB; Schifferli JA; Hughes GR
    J Clin Lab Immunol; 1981 Nov; 6(3):251-5. PubMed ID: 7338885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The composition of pulmonary immune deposits in systemic lupus erythematosus.
    Eagen JW; Roberts JL; Schwartz MM; Lewis EJ
    Clin Immunol Immunopathol; 1979 Feb; 12(2):204-19. PubMed ID: 369753
    [No Abstract]   [Full Text] [Related]  

  • 10. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
    Guo H; Leung JC; Chan LY; Chan TM; Lai KN
    Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera.
    Grossmayer GE; Munoz LE; Weber CK; Franz S; Voll RE; Kern PM; Kalden JR; Schett G; Herrmann M; Gaipl US
    Ann Rheum Dis; 2008 Nov; 67(11):1626-32. PubMed ID: 18165321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of immune complexes in idiopathic thrombopenia].
    Bragiel I; Walewska I
    Acta Haematol Pol; 1980; 11(4):267-74. PubMed ID: 7293689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reduced phagocytosis of heat-aggregated human IgG by polymorphonuclear leucocytes from patients with systemic lupus erythematosus (author's transl)].
    Ikebe K; Okawa M; Aotsuka S; Yokohari R
    Ryumachi; 1980 Apr; 20(2):75-81. PubMed ID: 7384948
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice.
    Zachrau B; Finke D; Kropf K; Gosink HJ; Kirchner H; Goerg S
    Int Immunol; 2004 Dec; 16(12):1685-90. PubMed ID: 15477230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against C1q in systemic lupus erythematosus.
    Siegert CE; Breedveld FC; Daha MR
    Behring Inst Mitt; 1993 Dec; (93):279-86. PubMed ID: 8172577
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigen-independent activation of the first component of complement C1 by chemically crosslinked rabbit IgG-oligomers.
    Tschopp J; Schulthess T; Engel J; Jaton JC
    FEBS Lett; 1980 Apr; 112(2):152-4. PubMed ID: 7371851
    [No Abstract]   [Full Text] [Related]  

  • 17. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood.
    Salvesen B; Nielsen EW; Harboe M; Saugstad OD; Mollnes TE
    Mol Immunol; 2009 Feb; 46(4):688-94. PubMed ID: 18950866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series.
    Wager O; Lindström P; Räsänen JA; Kekomäki R; Ziola B; Salmi A; Isomäki H; Skrifvars B; Penttinen K
    Clin Exp Immunol; 1981 Oct; 46(1):149-60. PubMed ID: 7337967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding and activation of human precursor C1 by soluble aggregates of human and rabbit IgG.
    Doekes G; van Seggelen-van Zijp AC; van Es LA; Cats A; Daha MR
    Int Arch Allergy Appl Immunol; 1985; 78(3):256-9. PubMed ID: 4055078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.